Historical record - last NADAC effective date: 11/18/2015
Product Information
VENLAFAXINE HCL 37.5 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.3269 per EA under NDC 55111054690. Its NADAC has been published 106 times since Nov 28, 2013.
FDA first approved this application on Jun 13, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111054690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/18/2015
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078301FDA Approved
6/13/2008
TE Code
AB
On Market Since
6/16/2008
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 37.5 MG TABLET has been published 106 times since Nov 28, 2013, and over the history we have for it it has risen 7.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3269 per EA |
|---|---|
| All-time high | $0.3269 (Dec 2, 2015) |
| All-time low | $0.2730 (Sep 23, 2015) |
| Median price | $0.3010 |
| Average price | $0.3004 |
| Largest weekly change | +19.7% (Nov 18, 2015) |
| Weeks tracked | 106 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+7.6%
Last surveyed Dec 2, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Venlafaxine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Venlafaxine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 37.5 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.3269 per EA (NDC 55111054690), effective Dec 2, 2015.
How has the price of VENLAFAXINE HCL 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 37.5 MG TABLET has risen 7.6%. It has been tracked across 106 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 37.5 MG TABLET?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL 37.5 MG TABLET has ranged from a low of $0.2730 (Sep 23, 2015) to a high of $0.3269 (Dec 2, 2015), with a median of $0.3010 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 37.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VENLAFAXINE HCL 37.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VENLAFAXINE HCL 37.5 MG TABLET?
VENLAFAXINE HCL 37.5 MG TABLET (NDC 55111054690) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.